Art

J-GLOBAL ID：201902280528699033   Reference number：19A2648369

Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial

慢性心不全および駆出率保持患者における罹患率および死亡率に対するempグリフロジンによるナトリウム-グルコース共輸送体2阻害の効果の評価: Emperor保存試験の根拠と設計【JST・京大機械翻訳】

Author (16)： Anker Stefan D. (Department of Cardiology (CVK) and Berlin Institute of Health Centre for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site, Berlin, Germany) ,  Butler Javed (University of Mississippi School of Medicine, Jackson, MI, USA) ,  Filippatos Gerasimos S. (School of Medicine, National and Kapodistrian University of Athens, Athens University Hospital Attikon, Athens, Greece) ,  Filippatos Gerasimos S. (School of Medicine, University of Cyprus, Nicosia, Cyprus) ,  Jamal Waheed (Boehringer Ingelheim International GmbH, Ingelheim, Germany) ,  Salsali Afshin (Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA) ,  Schnee Janet (Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA) ,  Kimura Karen (Boehringer Ingelheim Canada Ltd, Burlington, ON, Canada) ,  Zeller Cordula (Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany) ,  George Jyothis (Boehringer Ingelheim International GmbH, Ingelheim, Germany) ,  Brueckmann Martina (Boehringer Ingelheim International GmbH, Ingelheim, Germany) ,  Brueckmann Martina (Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany) ,  Zannad Faiez (Inserm INI-CRCT, CHRU, University of Lorraine, Nancy, France) ,  Packer Milton (Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA) ,  Packer Milton (Imperial College, London, UK) ,  on behalf of the EMPEROR-Preserved Trial Committees and Investigators
Material： European Journal of Heart Failure
Volume： 21  Issue： 10  Page： 1279-1287  Publication year： 2019 
JST Material Number： W2568A  ISSN： 1388-9842  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： BACKGROUND: The principal biol...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2648369&from=J-GLOBAL&jstjournalNo=W2568A") }}

Thesaurus term： *sodium ,  pathophysiology ,  left ventricular ejection fraction ,  heart ,  fibrous disease ,  *cardiac insufficiency ,  *mortality ,  recurrence ,  biomarker ,  inflammation
Semi thesaurus term： 阻害剤 ,  左心室 ,  拡張期心不全 ,  *駆出率 , 【Automatic Indexing@JST】

Author keywords (4)： Heart failure ,  Diabetes ,  SGLT2 inhibitors ,  Trial design

JST classification (2)： Cardiovascular system diseases  (GJ03000C) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Empagliflozin

Terms in the title (14)： 慢性心不全 ,  駆出率 ,  患者 ,  罹患率 ,  死亡 ,  ナトリウム ,  グルコース ,  共輸送体 ,  阻害 ,  評価 ,  保存 ,  試験 ,  根拠 ,  設計